» Articles » PMID: 38863927

Impact of Ultrasound Elastography in Evaluating Bethesda Category IV Thyroid Nodules with Histopathological Correlation

Overview
Specialty Endocrinology
Date 2024 Jun 12
PMID 38863927
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Fine needle aspiration (FNA) is the gold standard method recommended in the diagnosis of thyroid nodules. Bethesda IV cytology results are identified in 7-9% of nodules investigated through FNA, with reported malignancy rate in a wide range of 10-40%. The recommended treatment is either surgical or risk additional molecular testing before surgery. However, a large number of nodules belonging to this category (60-80%) are observed to be benign after surgical excision, which can put the patient at risk of unnecessary surgical morbidity. This study aimed to assess the diagnostic performance of conventional ultrasound, the ACR TI-RADS score and elastography in cases of Bethesda IV cytology on FNA.

Methods: We evaluated ninety-seven consecutive cases with Bethesda category IV results on FNA by using conventional B-mode ultrasound, qualitative strain or shear-wave elastography (Hitachi Preirus Machine, Hitachi Inc., Japan and Aixplorer Mach 30 Supersonic Imagine, Aix-en-Provence, France) and all nodules were classified according to the ACR TI-RADS system. Conventional ultrasound was used to categorize the nodules as potentially malignant based on the following features: hypoechogenicity, inhomogeneity, a taller than wide shape, irregular margins, presence of microcalcifications, an interrupted thyroid capsule and suspicious cervical lymph nodes. Elastography classified nodules with increased stiffness as suspicious for malignancy.

Results: We considered pathology results as the gold standard diagnosis, finding that 32 out of 97 nodules were carcinomas (33%) and 65 out of 97 were benign nodules (67%). The benign group included twenty cases of non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). Finally, we compared ultrasound data with pathology results, which showed that nineteen out of the 32 malignant nodules presented with increased stiffness on elastography (p=0.0002). On conventional ultrasound, we found that microcalcifications (p=0.007), hypoechogenicity and irregular margins (p=0.006) are features which can distinguish between benign and malignant nodules with statistical significance.

Discussion: Integrating elastography as a parameter of the ACR TI-RADS score in the evaluation of Bethesda category IV nodules showed a sensitivity of 90.62% in detecting thyroid cancer cases (p=0.006). We can conclude that elastographic stiffness as an addition to high risk features observed on conventional ultrasound improves the detection of malignant nodules in cases with Bethesda IV cytology.

Citing Articles

Role of clinicopathologic and sonographic characteristics for the management of patients with cytological diagnosis of thyroid follicular neoplasm.

Wu H, Cao Z, Zhang Q, Liu Z Gland Surg. 2024; 13(11):1996-2009.

PMID: 39678417 PMC: 11635570. DOI: 10.21037/gs-24-337.

References
1.
Russ G, Royer B, Bigorgne C, Rouxel A, Bienvenu-Perrard M, Leenhardt L . Prospective evaluation of thyroid imaging reporting and data system on 4550 nodules with and without elastography. Eur J Endocrinol. 2013; 168(5):649-55. DOI: 10.1530/EJE-12-0936. View

2.
Stoian D, Borcan F, Petre I, Mozos I, Varcus F, Ivan V . Strain Elastography as a Valuable Diagnosis Tool in Intermediate Cytology (Bethesda III) Thyroid Nodules. Diagnostics (Basel). 2019; 9(3). PMC: 6787586. DOI: 10.3390/diagnostics9030119. View

3.
Kamaya A, Tahvildari A, Patel B, Willmann J, Jeffrey R, Desser T . Sonographic Detection of Extracapsular Extension in Papillary Thyroid Cancer. J Ultrasound Med. 2015; 34(12):2225-30. DOI: 10.7863/ultra.15.02006. View

4.
Li F, Pan D, Wu Y, Peng J, Li Q, Gui X . Ultrasound characteristics of thyroid nodules facilitate interpretation of the malignant risk of Bethesda system III/IV thyroid nodules and inform therapeutic schedule. Diagn Cytopathol. 2019; 47(9):881-889. PMC: 6772092. DOI: 10.1002/dc.24248. View

5.
Cavalheiro B, Leite A, Matos L, Palermo Miazaki A, Marcel Ientile J, Kulcsar M . Malignancy Rates in Thyroid Nodules Classified as Bethesda Categories III and IV: Retrospective Data from a Tertiary Center. Int J Endocrinol Metab. 2018; 16(1):e12871. PMC: 5903393. DOI: 10.5812/ijem.12871. View